Geron reported $-21.29M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Amgen USD 5.14B 775M Dec/2025
Bio Techne USD 116.71M 13.29M Mar/2026
Cassava Sciences USD -11.73M 33.44M Sep/2025
Cytokinetics USD -169.32M 19.48M Mar/2026
Esperion Therapeutics USD -9.93M 24.99M Sep/2025
Exelixis USD 258.29M 15.43M Mar/2026
Genmab DKK 186M 291M Dec/2025
Geron USD -21.29M 11.82M Dec/2025
Gilead Sciences USD 3.02B 1.01B Dec/2025
Incyte USD 367.97M 46.53M Mar/2026
MacroGenics USD 21.95M 55.39M Sep/2025
Novartis USD 5.3B 530M Mar/2026
Novavax USD 19.36M 190.79M Dec/2025